Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Walter-Sack

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|August 30, 2007
Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecidJ Rengelshausen, C Göggelmann, J Burhenne, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Lack of accumulation of midazolam in plasma and lipoprotein fractions during intravenous lipid infusions in patients on artificial respirationI Walter-Sack, J X de Vries, J Rudi, et al.
The Clinical Investigator|March 1, 1993
Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?I Walter-Sack, J X de Vries, C Kreiner, et al.
The Clinical Investigator|December 1, 1993
Self-medication for abdominal discomfort resulting in life-threatening consequencesT Schlenker, R Raedsch, J X DeVries, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Variation of benzbromarone elimination in man--a population studyI Walter-Sack, U Gresser, M Adjan, et al.
Journal of Neurology|November 18, 2000
Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patientsM Schwaninger, P Ringleb, A Annecke, et al.
Scandinavian Journal of Gastroenterology|April 1, 1994
Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatmentJ Rudi, R Raedsch, C Gerteis, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 10, 2008
Calcium balance during calcitriol and paricalcitol administration in healthy humansV Hafner, C Rutsch, R Ding, et al.
Deutsche Medizinische Wochenschrift (1946)|August 1, 1997
[Secondary resistance to coumarin derivatives in a patient with a hypercoagulability syndrome]C Marburger, D Maclachian, O Haisken, et al.
Journal of the American Society of Nephrology : JASN|January 24, 1998
D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patientsC Bommer, E Werle, I Walter-Sack, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
International Journal of Clinical Pharmacology and Therapeutics|August 30, 2007
Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecidJ Rengelshausen, C Göggelmann, J Burhenne, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Lack of accumulation of midazolam in plasma and lipoprotein fractions during intravenous lipid infusions in patients on artificial respirationI Walter-Sack, J X de Vries, J Rudi, et al.
The Clinical Investigator|March 1, 1993
Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?I Walter-Sack, J X de Vries, C Kreiner, et al.
The Clinical Investigator|December 1, 1993
Self-medication for abdominal discomfort resulting in life-threatening consequencesT Schlenker, R Raedsch, J X DeVries, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Variation of benzbromarone elimination in man--a population studyI Walter-Sack, U Gresser, M Adjan, et al.
Journal of Neurology|November 18, 2000
Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patientsM Schwaninger, P Ringleb, A Annecke, et al.
Scandinavian Journal of Gastroenterology|April 1, 1994
Plasma kinetics and biliary excretion of colchicine in patients with chronic liver disease after oral administration of a single dose and after long-term treatmentJ Rudi, R Raedsch, C Gerteis, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 10, 2008
Calcium balance during calcitriol and paricalcitol administration in healthy humansV Hafner, C Rutsch, R Ding, et al.
Deutsche Medizinische Wochenschrift (1946)|August 1, 1997
[Secondary resistance to coumarin derivatives in a patient with a hypercoagulability syndrome]C Marburger, D Maclachian, O Haisken, et al.
Journal of the American Society of Nephrology : JASN|January 24, 1998
D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patientsC Bommer, E Werle, I Walter-Sack, et al.
Pageof 7